Skip to content

Role of Homoeopathy in Migraine

Efficacy of Individualised Homoeopathic Medicine versus Lac Defloratum in Centesimal scale for the Management of Migraine - A Single Blind Randomised Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094487
Enrollment
60
Registered
2025-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicine: Individualised homoeopathic medicines will be prescribed based on detailed case taking, symptom totality formation, and repertorization using appro

Sponsors

Nehru Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals aged between 20 and 60 years, of various socioeconomic background, shall be considered eligible for inclusion in the study. 2.Participants of all genders will be enrolled in the trial. 3.Those cases fulfilling the International Headache Society, diagnostic criteria for migraine. 4.Patient giving written consent form.

Exclusion criteria

Exclusion criteria: 1.Individuals with a diagnosed psychiatric disorder. 2.Pregnant and lactating individuals. 3.Patients diagnosed with any form of malignancy. 4.Individuals who are immunocompromised. 5.Patients requiring emergency medical intervention at the time of recruitment. 6.Individuals with uncontrolled systemic hypertension.

Design outcomes

Primary

MeasureTime frame
The Migraine Disability Assessment (MIDAS) questionnaireTimepoint: At Baseline and after 4 months of Treatment

Secondary

MeasureTime frame
NILTimepoint:

Countries

India

Contacts

Public ContactDr Mehr Singh

Nehru Homoeopathic Medical College and Hospital

rakeshthakkar14@gmail.com8851006347

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026